Integrating these findings, we hypothesized that PSMD12 might exert its function through CDK1, acting on both the G2/M checkpoint regulatory network and the PI3K/AKT/mTOR signaling cascade, thus influencing the progression of HCC. The gene discussed is MTOR; the disease is hepatocellular carcinoma.